The level of NF-κB activity was high in malignant basal-like breast cancer as reported [1, 6], whereas Tob expression in cancers of the malignant subtypes (basal-like and claudin-low) was low (Fig. 2a). Here, NFKB1 is linked to breast carcinoma.